Clinical & Translational Research

NIA-designated Alzheimer’s Disease Research Centers (ADRCs) serve as a national resource for research on the nature of Alzheimer’s disease (AD) and AD-related dementias (ADRD) and the development of more effective approaches to prevention, diagnosis, care, and therapy. They create shared resources that support dementia-relevant research.

Josephine Egan , M.D., Chief

Chee Chia, M.D., Associate Research Physician, Deputy Clinical Director

Giovanna Fantoni, Ph.D. , Facility Head

NIH has published two MFMU Requests for Applications (RFAs): RFA-HD-23-016: NICHD MFMU Network: Clinical Centers (UG1 Clinical Trial Optional) and RFA-HD-23-017: NICHD MFMU Network: Data Coordinating Center (U24 Clinical Trial Optional) .

Josephine Egan , MD, Chief

Chee Chia, MD , Associate Research Physician

Richard Spencer , Ph.D., M.D., Chief

Bryan J. Traynor , M.D., Ph.D., Chief

The Neuromuscular Diseases Research Section investigates the causes and biology of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Our focus is on turning discoveries into better diagnosis and faster development of treatments. We combine large-scale human genetics with detailed molecular profiling to understand disease processes, improve patient grouping, and create biomarkers and outcome tools for clinical trials.

Nigel H. Greig , Ph.D., Chief